Increased susceptibility of vault poly(ADP-ribose) polymerase-deficient mice to carcinogen-induced tumorigenesis

被引:44
作者
Raval-Fernandes, S
Kickhoefer, VA
Kitchen, C
Rome, LH
机构
[1] Univ Calif Los Angeles, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90095 USA
关键词
D O I
10.1158/0008-5472.CAN-05-0770
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Vault poly(ADP-ribose) polymerase (VPARP) and telomerase-associated protein 1 (TEP1) are components of the vault ribonucleoprotein complex. Vaults have been implicated in multidrug resistance of human tumors and are thought to be involved in macromolecular assembly and/or transport. Previous studies showed that VPARP-deficient mice were viable, fertile, and did not display any vault-related or telomerase-related phenotype, whereas disruption of telomerase-associated protein I in mice led to reduced stability of the vault RNA and affected its stable association with vaults, although there were no telomerase-related changes. In this study, we evaluated the susceptibility of Vparp(-/-) and Tep1(-/-) mice to dimethyllrydrazine-induced colon tumorigenesis and urethane-induced lung tumorigenesis. Mice received i.p. injections of either 1 g/kg body weight of urethane twice a week for 2 weeks or 20 mg/kg body weight of dimethylhydrazine once a week for 10 weeks and were analyzed after 10 and 60 weeks, respectively. The colon tumor incidence and multiplicity were significantly higher and colon tumor latency was significantly shorter in Vparp(-/-) mice compared with wild-type mice. Increased colon tumor incidence, multiplicity, and reduced tumor latency were also seen in Tep1(-/-) mice, however, these results were statistically not significant. Lung tumor multiplicities were increased in both Vparp(-/-) and Tep1(-/-) mice but were not significant. The increase in carcinogen-induced tumors in VPARP-deficient mice is the only phenotype observed to date, and suggests a possible role for VPARP, directly or indirectly, in chemically induced neoplasia.
引用
收藏
页码:8846 / 8852
页数:7
相关论文
共 67 条
[1]   The PARP superfamily [J].
Amé, JC ;
Spenlehauer, C ;
de Murcia, G .
BIOESSAYS, 2004, 26 (08) :882-893
[2]   Low-level doxorubicin resistance in benzo[a]pyrene-treated KB-3-1 cells is associated with increased LRP expression and altered subcellular drug distribution [J].
Cheng, SH ;
Lam, W ;
Lee, ASK ;
Fung, KP ;
Wu, RSS ;
Fong, WF .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2000, 164 (02) :134-142
[3]   p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis [J].
Chin, L ;
Artandi, SE ;
Shen, Q ;
Tam, A ;
Lee, SL ;
Gottlieb, GJ ;
Greider, CW ;
DePinho, RA .
CELL, 1999, 97 (04) :527-538
[4]  
CHUGANI DC, 1993, J CELL SCI, V106, P23
[5]   Functional interaction between poly(ADP-ribose) polymerase 2 (PARP-2) and TRF2:: PARP activity negatively regulates TRF2 [J].
Dantzer, F ;
Giraud-Panis, MJ ;
Jaco, I ;
Amé, JC ;
Schultz, I ;
Blasco, M ;
Koering, CE ;
Gilson, E ;
Ménissier-de Murcia, J ;
de Murcia, G ;
Schreiber, V .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (04) :1595-1607
[6]   Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells [J].
deMurcia, JM ;
Niedergang, C ;
Trucco, C ;
Ricoul, M ;
Dutrillaux, B ;
Mark, M ;
Oliver, FJ ;
Masson, M ;
Dierich, A ;
LeMeur, M ;
Walztinger, C ;
Chambon, P ;
deMurcia, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) :7303-7307
[7]  
di Fagagna FD, 1999, NAT GENET, V23, P76
[8]  
DRUCKREY E, 1970, CARCINOMA COLON ANTE, P267
[9]   DIFFERENTIAL SUSCEPTIBILITY OF 4 MOUSE STRAINS TO INDUCTION OF MULTIPLE LARGE-BOWEL NEOPLASMS BY 1,2-DIMETHYLHYDRAZINE [J].
EVANS, JT ;
HAUSCHKA, TS ;
MITTELMAN, A .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 52 (03) :999-1000
[10]  
FIALA ES, 1977, CANCER, V40, P2436, DOI 10.1002/1097-0142(197711)40:5+<2436::AID-CNCR2820400908>3.0.CO